| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 09/17/1998 | WO1998040094A1 Hydrophilic binary systems for the administration of cyclosporine |
| 09/17/1998 | WO1998040093A1 Method of antagonizing the human src sh2 domain |
| 09/17/1998 | WO1998040092A1 Dolastatin-15 derivatives in combination with taxanes |
| 09/17/1998 | WO1998040091A1 Microbicidal peptides and methods of use |
| 09/17/1998 | WO1998040090A1 Methods for inhibiting bacterial cytotoxicity |
| 09/17/1998 | WO1998040089A1 Recombinant vasoactive protein from salivary gland of the black fly |
| 09/17/1998 | WO1998040087A2 USE OF HUMAN α1-ACID GLYCOPROTEIN FOR PRODUCING A PHARMACEUTICAL PREPARATION |
| 09/17/1998 | WO1998040065A1 Hydroxy and ether-containing oxyalkylene esters and uses thereof |
| 09/17/1998 | WO1998040055A2 Anti-epileptogenic agents |
| 09/17/1998 | WO1998040051A1 Lipophilic binary systems for the administration of lipophilic compounds |
| 09/17/1998 | WO1998039967A1 A method for treating or preventing alzheimer's disease |
| 09/17/1998 | WO1998033937A3 GENOMIC SEQUENCE OF THE HUMAN ν-OPIOID RECEPTOR GENE AND THE VARIANTS, POLYMORPHISMS AND MUTATIONS THEREOF |
| 09/17/1998 | WO1998033813A3 Method for accelerating healing of thermal injuries |
| 09/17/1998 | WO1998031394A3 Tissue factor methods and compositions for coagulation and tumor treatment |
| 09/17/1998 | WO1998029565A3 Novel method for testing the differentiation status in pancreatic cells of a mammal |
| 09/17/1998 | WO1998029138A3 Compositions and methods for tumour therapy |
| 09/17/1998 | WO1998026747A3 Superantigen based methods and compositions for treatment of diseases |
| 09/17/1998 | WO1998026046A3 A novel transcription factor expressed in cycling cells, nucleic acid molecules encoding said transcription factor and its promoter region and uses thereof |
| 09/17/1998 | WO1998024905A3 Secreted proteins and polynucleotides encoding them |
| 09/17/1998 | WO1998021972A3 Compounds with improved inductive effect on cartilage and bones |
| 09/17/1998 | WO1998007850A3 Agents for pre-symptomatic detection and therapeutic targeting of alzheimer's disease and down syndrome in humans |
| 09/17/1998 | DE19710926A1 DNA zum Nachweis von Veränderungen des Chromosoms 7 DNA for the detection of changes in the chromosome 7 |
| 09/17/1998 | DE19710907A1 Ascorbinsäure als Adjuvans in der Chemo- und Strahlentherapie von Malignomen Ascorbic acid as an adjuvant in chemotherapy and radiotherapy of malignancies |
| 09/17/1998 | DE19710190A1 Aktivierter Vitamin K-abhängiger Blutfaktor und Verfahren zu dessen Herstellung Activated vitamin K-dependent blood factor and process for its preparation |
| 09/17/1998 | DE19708713A1 Verwendung von anti-CD44 Antikörpern enthaltenden Präparationen zur Behandlung bestimmter Tumore und zur Unterdrückung von Immunreaktionen Using anti-CD44 antibodies containing preparations for the treatment of certain tumors and for the suppression of immune responses |
| 09/17/1998 | CA2727634A1 Calcium fluoride phosphate complexes |
| 09/17/1998 | CA2323889A1 A method for treating or preventing alzheimer's disease |
| 09/17/1998 | CA2297164A1 Dolastatin 15 derivatives with carbonyl and heterocyclic functionalities at the c-terminus |
| 09/17/1998 | CA2284518A1 Anti-alphabeta3 humanized monoclonal antibodies |
| 09/17/1998 | CA2284514A1 Dna molecule encoding for cellular uptake of mycobacterium tuberculosis and uses thereof |
| 09/17/1998 | CA2284137A1 Prostate specific antigen substrates |
| 09/17/1998 | CA2284122A1 Activated vitamin k-dependent blood factor and method for the production thereof |
| 09/17/1998 | CA2284084A1 A novel cell surface receptor for hiv retroviruses, therapeutic and diagnostic uses |
| 09/17/1998 | CA2284001A1 Cytoprotective agents comprising monoamine oxidase inhibitors |
| 09/17/1998 | CA2283954A1 Preventive and therapeutic compositions for drug induced nephropathy and hepatitis |
| 09/17/1998 | CA2283780A1 Lipophilic binary systems for the administration of lipophilic compounds |
| 09/17/1998 | CA2283746A1 Antibodies for inhibiting blood coagulation and methods of use thereof |
| 09/17/1998 | CA2283678A1 28 human secreted proteins |
| 09/17/1998 | CA2283626A1 Modified protein kinase a-specific oligonucleotides and methods of their use |
| 09/17/1998 | CA2283580A1 Use of human .alpha.1-acid glycoprotein for producing a pharmaceutical preparation |
| 09/17/1998 | CA2283490A1 Fiv vaccine |
| 09/17/1998 | CA2283472A1 Method of antagonizing the human src sh2 domain |
| 09/17/1998 | CA2283461A1 Adenoviral vectors with modified tropism |
| 09/17/1998 | CA2283313A1 Anti-epileptogenic agents |
| 09/17/1998 | CA2283296A1 Growth factor receptor binding protein |
| 09/17/1998 | CA2283293A1 Method to diagnose and treat pathological conditions resulting from deficient ion transport such as pseudohypoaldosteronism type-1 |
| 09/17/1998 | CA2283195A1 Secreted proteins and polynucleotides encoding them |
| 09/17/1998 | CA2283193A1 Secreted proteins and polynucleotides encoding them |
| 09/17/1998 | CA2283173A1 Hydroxy and ether-containing oxyalkylene esters and uses thereof |
| 09/17/1998 | CA2282807A1 Compositions and methods for treating infections using cationic peptides alone or in combination with antibiotics |
| 09/17/1998 | CA2254785A1 Antisense base sequences |
| 09/17/1998 | CA2252711A1 An agent for preventing and/or treating multiple organ failure |
| 09/17/1998 | CA2232751A1 Novel compounds |
| 09/16/1998 | EP0864652A1 Expression of a foamy virus envelope protein |
| 09/16/1998 | EP0864585A1 Interleukin-18-receptor proteins |
| 09/16/1998 | EP0864584A1 Lipopetide from Actinoplanes sp. with pharmacological properties, process for its preparation and its use |
| 09/16/1998 | EP0864323A1 Pharmaceutical preparation for oral application containing a histamine-immunoglobulin complex |
| 09/16/1998 | EP0863992A1 Product and process to regulate actin polymerization |
| 09/16/1998 | EP0863988A1 Recombinant hiv and modified packaging cells and method for treating acquired immune deficiency syndrome |
| 09/16/1998 | EP0863987A2 Vectors and methods for gene transfer to cells |
| 09/16/1998 | EP0863984A1 Methods and compositions for the diagnosis and treatment of cancer |
| 09/16/1998 | EP0863982A1 Synthetic hpv11 virus-like particles |
| 09/16/1998 | EP0863981A1 Detection, prevention and treatment of papillomatous digital dermatitis |
| 09/16/1998 | EP0863918A1 Method for control of functionality during cross-linking of hemoglobins |
| 09/16/1998 | EP0863917A1 Targeted cytotoxic anthracycline analogs |
| 09/16/1998 | EP0863916A1 Polyfluoroalkyl tryptophan tripeptide thrombin inhibitors |
| 09/16/1998 | EP0863915A1 ACYLATED ENOL DERIVATIVES OF $g(a)-KETOESTERS AND $g(a)-KETOAMIDES |
| 09/16/1998 | EP0863911A1 ANTISENSE OLIGONUCLEOTIDE MODULATION OF raf GENE EXPRESSION |
| 09/16/1998 | EP0863900A1 Process for the preparation of a growth hormone secretagogue |
| 09/16/1998 | EP0863885A2 Novel macrocyclic compounds as metalloprotease inhibitors |
| 09/16/1998 | EP0863883A1 Alpha-(1,3-dicarbonylenol ether) methyl ketones as cysteine protease inhibitors |
| 09/16/1998 | EP0863766A1 Methods for treating photoreceptors using glial cell line-derived neurotrophic factor (gdnf) protein product |
| 09/16/1998 | EP0863765A1 Pharmaceutical compositions of macrolides or cyclosporine with a polyethoxylated saturated hydroxy-fatty acid |
| 09/16/1998 | EP0863764A1 Method for analyzing isomers of enalapril and enalaprilat |
| 09/16/1998 | EP0863762A1 Methods of production and use of liquid formulations of plasma proteins |
| 09/16/1998 | EP0863759A1 Use of a combination of pentoxifylline and type i interferons for treating multiple sclerosis |
| 09/16/1998 | EP0863753A1 Perfluoroalkyl substituted metallo-beta-lactamase inhibitors and method for the preparation of trifluoromethylketone derivatives |
| 09/16/1998 | EP0863745A1 Thermosensitive biodegradable polymers based on poly(ether-ester) block copolymers |
| 09/16/1998 | EP0863729A1 Implantable controlled release device to deliver drugs directly to an internal portion of the body |
| 09/16/1998 | EP0833629A4 Aryl acrylic acid derivatives useful as protein tyrosine phosphatase inhibitors |
| 09/16/1998 | EP0724637B1 Corticotropin-releasing factor 2 receptors |
| 09/16/1998 | EP0706574B1 Methods for peptide synthesis and purification |
| 09/16/1998 | EP0666920B1 Thrombin activatable plasminogen derivatives |
| 09/16/1998 | EP0662841B1 Pharmaceutical composition for site-specific release of a clot-dissolving protein |
| 09/16/1998 | EP0661930B1 Viscous liquid xylitol compositions and method for preparing same |
| 09/16/1998 | EP0649432B1 Fluorine comprising dipeptides as inhibitors against human leucocyte elastase inhibitors |
| 09/16/1998 | EP0644897B1 New peptides and proteins, process for their preparation and their use as cholesterol acceptors |
| 09/16/1998 | EP0624095B1 Methods and compositions for reducing blood loss |
| 09/16/1998 | EP0620854B1 Expression and purification of recombinant soluble tissue factor |
| 09/16/1998 | EP0554356B1 A monoclonal antibody |
| 09/16/1998 | EP0530265B1 Dna encoding human 5-ht 1d receptors and uses thereof |
| 09/16/1998 | EP0485430B1 Methods and compositions for ameliorating the symptoms of sepsis |
| 09/16/1998 | CN1193353A Allergen-XCD32 fusion proteins |
| 09/16/1998 | CN1193352A Human chitinase, its recombinant production, its use for decomposing chitin, and its use in therapy or prophylaxis against infection diseases |
| 09/16/1998 | CN1193350A Antigen non-specific glycosylation inhibiting factor derivatives |
| 09/16/1998 | CN1193325A Cell adhension inhibitors |
| 09/16/1998 | CN1193280A Control of CD44 gene expression for therapeutic use |
| 09/16/1998 | CN1193278A Chemical compounds |
| 09/16/1998 | CN1193022A Heterocyclic compound used as leucocyte adherence inhibitor and VLA-4 antagonist |
| 09/16/1998 | CN1192929A Oral medicinal preparation |